Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

ConclusionsCompared to targeted testing approaches, eGT can increase the yield of detection of hereditary cancer predisposition in patients with a range of tumors, allowing opportunities for enhanced surveillance and intervention. The benefits of performing eGT should be weighed against the added number of VUSs identified with this approach.
Source: Genome Medicine - Category: Genetics & Stem Cells Source Type: research